EGFR and neoplasm: Like the previously described NKAB-ErbB2 protein, which is selective for the receptor tyrosine kinase ErbB2 (HER2) [27], NKAB-EGFR enhanced the activity of peripheral blood NK cells from healthy donors against tumor cells expressing the cognate target antigen.